More News! 22 Nov 2018
First Drug for Rare Inflammation Syndrome Approved by FDA
The FDA has approved the first drug for the treatment of a rare condition in which the body produces too…
Novimmune
- Latest Posts
Best in Biotech 20 Feb 2018
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our…
News and Trends 18 Jul 2017
Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche
Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune that could improve the treatment…
Best in Biotech 30 May 2017
In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight
Geneva is the largest city in French-speaking Switzerland, a financial powerhouse, home to the United Nations and known as the…
ADVERTISEMENT
News and Trends 4 Jan 2017
This British Biotech is buying its way into the Crowded NASH Space
Tiziana Life Sciences is acquiring candidates to gain leverage in the profitable NASH market, where there's currently a fierce competition.…
